This Healthcare Stock Is the Best Performer in the S&P 500 After FDA Approval
Insulet stock was surging Tuesday after the healthcare company said its Omnipod 5 Insulin System got approval from the Food and Drug Administration. Insulet said in a news release Tuesday that its Omnipod 5 Automated Insulin Delivery System has been cleared by the FDA for use by people over 18 with Type 2 diabetes. The Omnipod 5 is an insulin delivery system that is used to manage blood sugar levels.